Literature DB >> 18662976

Renal replacement therapy in lupus nephritis.

Anke Rietveld, Jo H M Berden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18662976     DOI： 10.1093/ndt/gfn429

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  3 in total

1.  Peritoneal dialysis treatment for severe lupus nephritis patients complicated with essential organ dysfunction.

Authors:  Yan Zhou; Yusheng Yu; Zheng Tang; Shijun Li; Weixin Hu; Chunlei Luo; Zhihong Liu
Journal:  Exp Ther Med       Date:  2015-10-14       Impact factor: 2.447

2.  Comparison of clinical outcomes by different renal replacement therapy in patients with end-stage renal disease secondary to lupus nephritis.

Authors:  Seok-Hui Kang; Byung-Ha Chung; Sun-Ryoung Choi; Ja-Young Lee; Hoon-Suk Park; In-O Sun; Bum-Soon Choi; Cheol-Whee Park; Yong-Soo Kim; Chul-Woo Yang
Journal:  Korean J Intern Med       Date:  2011-03-02       Impact factor: 3.165

3.  Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.

Authors:  George K Bertsias; Maria Tektonidou; Zahir Amoura; Martin Aringer; Ingeborg Bajema; Jo H M Berden; John Boletis; Ricard Cervera; Thomas Dörner; Andrea Doria; Franco Ferrario; Jürgen Floege; Frederic A Houssiau; John P A Ioannidis; David A Isenberg; Cees G M Kallenberg; Liz Lightstone; Stephen D Marks; Alberto Martini; Gabriela Moroni; Irmgard Neumann; Manuel Praga; Matthias Schneider; Argyre Starra; Vladimir Tesar; Carlos Vasconcelos; Ronald F van Vollenhoven; Helena Zakharova; Marion Haubitz; Caroline Gordon; David Jayne; Dimitrios T Boumpas
Journal:  Ann Rheum Dis       Date:  2012-07-31       Impact factor: 19.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.